Skip to main content
Top
Published in: Acta Diabetologica 4/2011

01-12-2011 | Short Communication

Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance

Authors: Kristine Færch, Allan Vaag

Published in: Acta Diabetologica | Issue 4/2011

Login to get access

Abstract

Metabolic flexibility reflects the ability to switch from lipid to carbohydrate oxidation during insulin stimulation. Impaired metabolic flexibility is related to insulin resistance and type 2 diabetes, but whether metabolic flexibility is impaired in individuals with the pre-diabetic states isolated impaired fasting glycaemia (i-IFG) and isolated impaired glucose tolerance (i-IGT) is unknown. Using the gold standard euglycaemic hyperinsulinaemic clamp technique combined with indirect calorimetry, we measured peripheral insulin sensitivity, lipid and glucose oxidation, and thus metabolic flexibility in 66 individuals with normal glucose tolerance (NGT, n = 20), i-IFG (n = 18) and i-IGT (n = 28). During insulin stimulation, individuals with i-IGT displayed reduced insulin sensitivity including reduced glucose oxidation. Interestingly, those with i-IFG exhibited reduced glucose oxidation and a slightly elevated lipid oxidation rate during insulin infusion despite having normal total peripheral glucose disposal. Thus, metabolic flexibility was significantly reduced in individuals with both i-IFG and i-IGT even after adjustment for BMI and insulin sensitivity. The data indicate that metabolic inflexibility may precede the development of overt peripheral insulin resistance in pre-diabetic individuals. However, prospective studies are needed to confirm this notion.
Literature
1.
go back to reference Vaag A, Lehtovirta M, Thye-Rönn P, Groop L, Evans J (2001) Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR). Diabet Med 18:533–540PubMedCrossRef Vaag A, Lehtovirta M, Thye-Rönn P, Groop L, Evans J (2001) Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR). Diabet Med 18:533–540PubMedCrossRef
2.
go back to reference Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203PubMedCrossRef Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203PubMedCrossRef
3.
go back to reference Vaag AA, Handberg A, Skott P, Richter EA, Beck-Nielsen H (1994) Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol 130:70–79PubMedCrossRef Vaag AA, Handberg A, Skott P, Richter EA, Beck-Nielsen H (1994) Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol 130:70–79PubMedCrossRef
4.
go back to reference Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 51:1271–1280PubMedCrossRef Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 51:1271–1280PubMedCrossRef
5.
go back to reference Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance—results from the veterans administration genetic epidemiology study. Diabetes 55:1430–1435PubMedCrossRef Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance—results from the veterans administration genetic epidemiology study. Diabetes 55:1430–1435PubMedCrossRef
6.
go back to reference Festa A, D’Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53:1549–1555PubMedCrossRef Festa A, D’Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53:1549–1555PubMedCrossRef
7.
go back to reference Færch K, Vaag A, Holst J, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853–861PubMedCrossRef Færch K, Vaag A, Holst J, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853–861PubMedCrossRef
8.
go back to reference Ruchat SM, Elks CE, Loos RJF et al (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46:217–226PubMedCrossRef Ruchat SM, Elks CE, Loos RJF et al (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46:217–226PubMedCrossRef
9.
go back to reference Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683PubMedCrossRef Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683PubMedCrossRef
10.
go back to reference Kelley DE, Mokan M, Mandarino LJ (1992) Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698–706PubMedCrossRef Kelley DE, Mokan M, Mandarino LJ (1992) Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698–706PubMedCrossRef
11.
go back to reference Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. AJP Endocrinol Metab 277:E1130–E1141 Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. AJP Endocrinol Metab 277:E1130–E1141
12.
go back to reference Galgani JE, Heilbronn LK, Azuma K et al (2008) Metabolic flexibility in response to glucose is not impaired in people with Type 2 diabetes after controlling for glucose disposal rate. Diabetes 57:841–845PubMedCrossRef Galgani JE, Heilbronn LK, Azuma K et al (2008) Metabolic flexibility in response to glucose is not impaired in people with Type 2 diabetes after controlling for glucose disposal rate. Diabetes 57:841–845PubMedCrossRef
13.
go back to reference Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Charlotta P (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377–386CrossRef Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Charlotta P (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377–386CrossRef
14.
go back to reference DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedCrossRef DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedCrossRef
15.
go back to reference Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMedCrossRef Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMedCrossRef
16.
go back to reference Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341–1350PubMedCrossRef Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341–1350PubMedCrossRef
17.
go back to reference Corpeleijn E, Mensink M, Kooi ME, Roekaerts PMHJ, Saris WHM, Blaak EE (2008) Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity 16:1025–1032PubMedCrossRef Corpeleijn E, Mensink M, Kooi ME, Roekaerts PMHJ, Saris WHM, Blaak EE (2008) Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity 16:1025–1032PubMedCrossRef
18.
go back to reference Storlien L, Oakes ND, Kelley DE (2004) Symposium 6: adipose tissue-liver-muscle interactions leading to insulin resistance—metabolic flexibility. Proc Nutr Soc 63:363–368PubMedCrossRef Storlien L, Oakes ND, Kelley DE (2004) Symposium 6: adipose tissue-liver-muscle interactions leading to insulin resistance—metabolic flexibility. Proc Nutr Soc 63:363–368PubMedCrossRef
19.
go back to reference Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, DeFronzo R (2008) Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 45:147–150PubMedCrossRef Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, DeFronzo R (2008) Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 45:147–150PubMedCrossRef
Metadata
Title
Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance
Authors
Kristine Færch
Allan Vaag
Publication date
01-12-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0245-x

Other articles of this Issue 4/2011

Acta Diabetologica 4/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.